Oct 18, 2017   SOURCE: PR NewsWire

Global $1.9 Bn 3D Bioprinters Market to 2025

DUBLIN, October 18, 2017 /PRNewswire/ --

The "Global 3D Bioprinters Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 - 2025" report has been added to Research and Markets' offering.

http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

The 3D bioprinters market was valued at USD 774.41 Mn in 2017, and is expected to reach USD 1,942.5 Mn by 2025, expanding at a CAGR of 18.8% from 2017 - 2025.

The global 3D bioprinters market is represented by key technologies namely, syringe based 3D bioprinting, laser based 3D bioprinting, magnetic levitation 3D bioprinting, inkjet based 3D bioprinting and valve-based 3D bioprinting. Among these syringe based 3D bioprinting is the largest segment and is anticipated to maintain its lead during the forecast period 2016 - 2022.

Pharmaceuticals segment accounted for a major share of 31.70% in the 3D bioprinting market. Drug development today is increasingly focusing on reducing side effects, improving treatment outcomes and deserting the one-size-fits-all' approach to medication management.

According to market experts competition in 3D bioprinting market is low and barriers are high. Competition is low due to presence of niche opportunities in the healthcare industry and barriers are high because the research is very specialized and requires a significant amount of investment, usually by the government or private donors, while the risks to profitability remain very high.

3D Systems, Inc. and Stratasys Ltd. dominate the 3D printer applications in healthcare market. The other upcoming key players such as Organovo, Inc. and EnvisionTEC, Inc. are expected to be one of the leading players in 3D bioprinting market in the near future.

Market Dynamics

Drivers

    --  Gap between patients waiting for organ transplant and available organ
        donors
    --  Rising demand for cost-efficient technology in drug development
        processes

Challenges

    --  3D Bioprinters of organs face restriction related to the raw materials
        applied for printing

Opportunities

    --  Prosthetics and Orthopedic implants manufactured with 3D Bioprinters
        technology is in developed stage

Key Market Movements:

    --  Gap between patients waiting for organ transplant and available organ
        donors
    --  Rising demand for cost-efficient technologies in drug development
        processes
    --  Growth in adoption of 3D bioprinted bone grafts and dental consumables

Key Topics Covered:

Chapter 1 Preface

Chapter 2 Executive Summary

Chapter 3 3D Bioprinters Market: Market Dynamics and Outlook

Chapter 4 Global 3D Bioprinters Market, by Technology

Chapter 5 Global 3D Bioprinters Market, by Application

Chapter 6 Global 3D Bioprinters Market, By Geography

Chapter 7 Company Profiles

    --  BioBots, Inc.
    --  TeVido BioDevices, LLC
    --  3D Dynamic Systems Ltd.
    --  Rokit, Inc.
    --  Aspect Biosystems Ltd.
    --  Cyfuse Biomedical K.K.
    --  Organovo Holdings, Inc.
    --  Stratasys Ltd.
    --  3D Systems, Inc.
    --  Envision TEC

For more information about this report visit https://www.researchandmarkets.com/research/qr3sf9/global_3d

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-19-bn-3d-bioprinters-market-to-2025-300539026.html

SOURCE Research and Markets